Journal: Frontiers in Public Health
Article Title: The emergence of carbapenemase-producing Enterobacterales in hospitals: a major challenge for a debilitated healthcare system in Lebanon
doi: 10.3389/fpubh.2023.1290912
Figure Lengend Snippet: Antibiotic susceptibility patterns of selected carbapenemase-producing Escherichia coli isolates for antibiotics considered last resort molecules using broth microdilution test (Sensititre), and interpreted according to the EUCAST guidelines ( 18 ).
Article Snippet: Additionally, 13 CP- E. coli isolates were selected according to their resistance phenotype, genotype, and MLST type for further determination of MIC values using broth microdilution (BMD) test (Sensititre, ThermoFisher, Grenoble, France) for a complementary list of novel beta-lactam and non-beta-lactam antibiotics of clinical and veterinary interest (i.e., ceftazidime/avibactam, ceftiofur, ceftaroline, ceftobiprole, aztreonam-avibactam, mecillinam, imipenem/relebactam, meropenem/vaborbactam, cefiderocol, eravacyclin, apramycin, gentamicin, neomycin, streptomycin, sulfonamides, and nitrofurantoin).
Techniques: